Home › NDC Lookup › RxCUI directory › RxCUI 1720975

52.6 ML gemcitabine 38 MG/ML Injection — RxCUI 1720975

RxNorm drug concept · Semantic clinical drug
RxCUI 1720975 Semantic clinical drug · SCD ● Current RxNorm concept 15 FDA products 21 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1720975
Official name52.6 ML gemcitabine 38 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asgemcitabine 2 GM per 52.6 ML Injection; gemcitabine 2 GM in 52.6 ML Injection; gemcitabine (as gemcitamine HCl) 2 GM per 52.6 ML Injection
FDA products mapped15
Package NDCs mapped21
Reported Medicaid activity (SDUD)16,346 prescriptions · 48 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Gemcitabine Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Gemcitabine is used to treat four types of cancer: advanced ovarian cancer that has come back after platinum-based chemo, metastatic breast cancer (combined with paclitaxel), non-s...
  • You'll receive gemcitabine through an IV (into a vein) at a clinic or infusion center — it's not a pill you take at home. Each infusion takes about 30 minutes, and it's typically g...
  • How is gemcitabine given, and what should I expect during infusion?
  • The most common side effects include nausea, vomiting, fatigue from low red blood cells, fever, rash, and swelling. Your blood counts will often drop during treatment, which is exp...
📖 Read our full Gemcitabine Injection guide →

🕸️ Concept Web — How 52.6 ML gemcitabine 38 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 52.6 ML gemcitabine 38 MG/ML Injection RxCUI 1720975

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Gemcitabine 12574
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Gemcitabine Injection 1718999
    • Gemcitabine Injectable Product 1156710
    • Injection 1649574
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Gemcitabine 38 MG/ML 1148918

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Gemcitabine 38 MG/ML SCDC · 1148918
  • Gemcitabine Injection SCDF · 1718999
  • Gemcitabine Injectable Product SCDG · 1156710

📦 FDA Products & Package NDCs

15 products · 21 package NDCs
21 package NDCs map to RxCUI 1720975 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00143-9340-01 1 VIAL in 1 CARTON (0143-9340-01) / 5.26 mL in 1 VIAL Gemcitabine Hikma Pharmaceuticals USA Inc. 2025-10-17
00143-9341-01 1 VIAL in 1 CARTON (0143-9341-01) / 26.3 mL in 1 VIAL Gemcitabine Hikma Pharmaceuticals USA Inc. 2025-10-17
00143-9342-01 1 VIAL in 1 CARTON (0143-9342-01) / 52.6 mL in 1 VIAL Gemcitabine Hikma Pharmaceuticals USA Inc. 2025-10-17
00409-0181-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0181-01) / 26.3 mL in... Gemcitabine Hospira, Inc. 2011-08-26
00409-0181-25 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0181-25) / 26.3 mL in... Gemcitabine Hospira, Inc. 2013-07-09
00409-0182-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0182-01) / 52.6 mL in... Gemcitabine Hospira, Inc. 2011-08-22
00409-0182-25 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0182-25) / 52.6 mL in... Gemcitabine Hospira, Inc. 2013-07-29
00409-0183-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0183-01) / 5.26 mL in... Gemcitabine Hospira, Inc. 2011-08-24
00409-0183-25 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0183-25) / 5.26 mL in... Gemcitabine Hospira, Inc. 2013-07-09
25021-0239-05 1 VIAL in 1 CARTON (25021-239-05) / 5.26 mL in 1 VIAL Gemcitabine Sagent Pharmaceuticals 2019-01-15
25021-0239-26 1 VIAL in 1 CARTON (25021-239-26) / 26.3 mL in 1 VIAL Gemcitabine Sagent Pharmaceuticals 2019-01-15
25021-0239-52 1 VIAL in 1 CARTON (25021-239-52) / 52.6 mL in 1 VIAL Gemcitabine Sagent Pharmaceuticals 2019-01-15
67457-0616-10 1 VIAL, SINGLE-DOSE in 1 CARTON (67457-616-10) / 5.26 mL in... Gemcitabine Mylan Institutional LLC 2018-01-03
67457-0617-30 1 VIAL, SINGLE-DOSE in 1 CARTON (67457-617-30) / 26.3 mL in... Gemcitabine Mylan Institutional LLC 2017-12-18
67457-0618-10 1 VIAL, SINGLE-DOSE in 1 CARTON (67457-618-10) / 52.6 mL in... Gemcitabine Mylan Institutional LLC 2017-12-18
71288-0117-06 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-117-06) / 5.26 mL in... Gemcitabine Meitheal Pharmaceuticals Inc. 2020-12-11
71288-0117-28 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-117-28) / 26.3 mL in... Gemcitabine Meitheal Pharmaceuticals Inc. 2020-12-11
71288-0117-54 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-117-54) / 52.6 mL in... Gemcitabine Meitheal Pharmaceuticals Inc. 2020-12-11
71288-0117-91 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-117-91) / 5.26 mL in... Gemcitabine Meitheal Pharmaceuticals Inc. 2020-12-11
71288-0117-92 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-117-92) / 26.3 mL in... Gemcitabine Meitheal Pharmaceuticals Inc. 2020-12-11
71288-0117-93 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-117-93) / 52.6 mL in... Gemcitabine Meitheal Pharmaceuticals Inc. 2020-12-11
Observed labelers: Hospira, Inc. (6) · Meitheal Pharmaceuticals Inc. (6) · Hikma Pharmaceuticals USA Inc. (3) · Mylan Institutional LLC (3) · Sagent Pharmaceuticals (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J9201 In gemcitabine hcl nos 200mg 18 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.